Board Of Directors
Jeffrey L. Sturchio, Chairman of the Board

Jeffrey L. Sturchio
President and CEO, Rabin Martin

Jeffrey L. Sturchio is President and CEO at Rabin Martin, a global health strategy consulting firm, and former President and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co. Inc., president of The Merck Company Foundation and chairman of the U. S. Corporate Council on Africa (CCA), whose 160 member companies represent some 85 percent of total US private sector investment in Africa. While at Merck & Co., Inc., for more than a decade he was a leader of the company’s global HIV/AIDS policy and was centrally involved in the UN/Industry Accelerating Access Initiative established in 2000 to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008).

He is chairman of the Corporate Council on Africa, chairman of the BroadReach Institute for Training and Education and a member of the boards of ACHAP, Friends of the Global Fight Against AIDS and the Museum of AIDS in Africa.  Dr. Sturchio is also currently a visiting scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Affairs; a principal of the Modernizing Foreign Assistance Network; Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations and the Arthur W. Page Society; and an advisor to amfAR, the Clinton Global Initiative, Intrahealth International and the NCD Alliance. He received an AB in history from Princeton University and a PhD in the history and sociology of science from the University of Pennsylvania. His publications include Noncommunicable diseases in the developing world: addressing global gaps in policy and research (edited with L. Galambos, Johns Hopkins University Press, 2013).

Board Members

Randy Broiles
ExxonMobil Production Company
 

Carolyn Campbell
ECP Private Equity
 

Antony Cook
Microsoft Corporation
 

Aliko Dangote
Dangote Industries Limited
 

Philip de Leon
AGCO
 

Gilles de Vignemont
PricewaterhouseCoopers
 

Samuel Dossou
Petrolin Group
 

Stephen Hayes
Corporate Council on Africa
 

Paul Hinks
Symbion Power
 

Jay Ireland
GE Africa, General Electric
 

Jude Kearney
Greenberg Traurig, LLP
 

Dan Kravets
Feeport-McMoRan
 

Demetrios Marantis
VISA, Inc. 

  Ali Moshiri
Chevron Corporation
 
Jim Ovia
Zenith Bank
 
David Picard
Caterpillar Inc.
 
Tarek Rabah
AstraZeneca
 
Raymond Rawlins
Corporate Council on Africa
 
Faisal Sabzwari
Procter & Gamble
 
Miguel Santos
The Boeing Company
 
Michael Spivey
Walmart
 
Paul Sullivan
Acrow Bridge
 
William Ward
Sentel
 
Diane Willkens
Development Finance International, Inc.
 
James Winkler
DAI
 
Anthony Winns
Lockheed Martin International